Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on March 24, 2025
Isoprenol Market is Projected to Reach USD 675.0 Million by 2035, Expanding at a 6.5% CAGR by 2035 | Fact.MR Report
GlobeNewswire
·
March 24, 2025
Rockville, MD , March 24, 2025 (GLOBE NEWSWIRE) -- The global Isoprenol Market was valued at USD 337.7 million in 2024 and expand at a CAGR of 6.5% to end up at USD 675.0 million by 2035.The global market for Isoprenol is essentially a dynamic industrial …
Mitolyn Weight Loss (EXPOSED) Buyers Unexpected Insights Reports 2025
GlobeNewswire
·
March 24, 2025
TALLMADGE, Ohio, March 24, 2025 (GLOBE NEWSWIRE) -- The prime cause for weight gain is seen to be predominantly because of the presence of a superfluous amount of white fats in the body which aids in the increment of the stored calories of the body. The …
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
GlobeNewswire
·
March 24, 2025
Treatment with UBX1325 resulted in vision gains comparable to aflibercept at weeks 24 and 36 in difficult-to-treat patient population UBX1325 was non-inferior to aflibercept at week 24 (>90% confidence interval), but did not meet statistical non- …
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024
GlobeNewswire
·
March 24, 2025
Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise with key data readouts expected in 2025 ORX750 Phase 2a CRYSTAL-1 study for the treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia ( …
Arsen Introduces AI-Powered Phishing Tests to Improve Social Engineering Resilience
GlobeNewswire
·
March 24, 2025
PARIS, March 24, 2025 (GLOBE NEWSWIRE) -- Arsen, a leading cybersecurity company specializing in social engineering defense, today announced the full release of Conversational Phishing, a groundbreaking feature embedded in its phishing simulation platform. …
Silicone Adhesives Market to Reach USD 2,647.1 Million by 2035, Growing at 6.2% CAGR | Fact.MR Report
GlobeNewswire
·
March 24, 2025
Rockville, MD, March 24, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the silicone adhesives market was valued at USD 1,365 million in 2024 and is expected to grow at a CAGR of 6.2% during the …
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
GlobeNewswire
·
March 24, 2025
EXTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical today announced the appointment of Kevin Kearney as Chief Commercial Officer (CCO). Kearney brings over 20 years of commercial leadership, business development, and strategic sales operations …
ProMIS Neurosciences Showcases Preclinical Data on Platform-Derived Antibody and Vaccines for Neurodegenerative Diseases at Alzheimer’s Disease/Parkinson’s Disease 2025 International Conference
GlobeNewswire
·
March 24, 2025
CAMBRIDGE, Massachusetts, March 24, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic misfolded proteins …
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
GlobeNewswire
·
March 24, 2025
Additional alignment with FDA on LX2006 planned pivotal study including protein expression co-primary endpoint: based on improvements in LVMI across participants with abnormal LVMI at baseline, frataxin expression to be evaluated for any increase from …
Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer
GlobeNewswire
·
March 24, 2025
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced the …
Kamada Updates on Withholding Tax Procedures on Previously Announced Special Cash Dividend to Shareholders
GlobeNewswire
·
March 24, 2025
REHOVOT, Israel and HOBOKEN, N.J., March 24, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the …
Wag! Reports Fourth Quarter and Full Year 2024 Results; Announces Review of Strategic Alternatives to Maximize Shareholder Value
GlobeNewswire
·
March 24, 2025
SAN FRANCISCO, March 24, 2025 (GLOBE NEWSWIRE) -- Wag! Group Co. (the “Company” or “Wag!”; Nasdaq: PET), which strives to be the number one platform to solve the service, product, and wellness needs of the modern U.S. pet household, today announced …
Transpire Delivers AI-Assisted Story Building with Case Concepts
GlobeNewswire
·
March 24, 2025
Chicago, Ill., March 24, 2025 (GLOBE NEWSWIRE) -- Transpire Technologies today announced the general availability of version 4 of its online litigation support platform and the introduction of the Case Concepts™ AI-assisted story building feature. Building …
Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-102, an Investigational Gene Editing Medicine Designed to Durably Lower Cholesterol After a Single Dose
GlobeNewswire
·
March 24, 2025
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced the clearance of its Investigational New Drug (IND) application by the U.S. Food …
Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress
GlobeNewswire
·
March 24, 2025
Clinical Complete Responses Observed with Single Low-Dose of Bel-sar in Patients with Intermediate and High-Risk NMIBC with Robust Cell-Mediated Immunity and Urothelial Field Effect Favorable Safety Profile; Only Grade 1 Drug-Related Adverse Events …
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in People Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping
GlobeNewswire
·
March 24, 2025
– Company on track to initiate ELEVATE-45-201 study in Q3 2025 – – ELEVATE-45 regulatory filings submitted in the EU, with regulatory review ongoing – – ELEVATE-45 is the second of three novel exon skipping Duchenne programs the Company expects to …
Rapid7 Appoints Three New Board Members
GlobeNewswire
·
March 24, 2025
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that it will appoint three new members to its Board of Directors: Wael Mohamed, Mike Burns and Kevin Galligan. These …
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
GlobeNewswire
·
March 24, 2025
Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two key measures of antiviral activity in preclinical bird flu models Results build on earlier positive findings of …
Larimar Therapeutics Provides Nomlabofusp Development Update and Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 24, 2025
FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval FDA recommended measuring skin FXN concentrations …
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services
GlobeNewswire
·
March 24, 2025
Represents first project to enter the ECO Synthesis™ Innovation Lab Core enzymes for ECO Synthesis™ technology have transitioned from research into development and scale-up as the first step in securing the raw materials supply chain REDWOOD CITY, Calif., …